vs
亚什兰（ASH）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是亚什兰的1.5倍（$585.5M vs $386.0M），亚什兰净利率更高（-3.1% vs -6.9%，领先3.8%），科睿唯安同比增速更快（-1.4% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $78.9M），过去两年科睿唯安的营收复合增速更高（-5.1% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
ASH vs CLVT — 直观对比
营收规模更大
CLVT
是对方的1.5倍
$386.0M
营收增速更快
CLVT
高出3.3%
-4.7%
净利率更高
ASH
高出3.8%
-6.9%
自由现金流更多
ASH
多$32.1M
$78.9M
两年增速更快
CLVT
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $585.5M |
| 净利润 | $-12.0M | $-40.2M |
| 毛利率 | 27.2% | 67.2% |
| 营业利润率 | -1.6% | 5.2% |
| 净利率 | -3.1% | -6.9% |
| 营收同比 | -4.7% | -1.4% |
| 净利润同比 | 92.7% | 61.3% |
| 每股收益（稀释后） | $-0.26 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHCLVT
| Q1 26 | — | $585.5M | ||
| Q4 25 | $386.0M | $617.0M | ||
| Q3 25 | $477.0M | $623.1M | ||
| Q2 25 | $463.0M | $621.4M | ||
| Q1 25 | $479.0M | $593.7M | ||
| Q4 24 | $405.0M | $663.0M | ||
| Q3 24 | $521.0M | $622.2M | ||
| Q2 24 | $544.0M | $650.3M |
净利润ASHCLVT
| Q1 26 | — | $-40.2M | ||
| Q4 25 | $-12.0M | $3.1M | ||
| Q3 25 | $31.0M | $-28.3M | ||
| Q2 25 | $-742.0M | $-72.0M | ||
| Q1 25 | $31.0M | $-103.9M | ||
| Q4 24 | $-165.0M | $-191.8M | ||
| Q3 24 | $17.0M | $-65.6M | ||
| Q2 24 | $6.0M | $-304.3M |
毛利率ASHCLVT
| Q1 26 | — | 67.2% | ||
| Q4 25 | 27.2% | 66.8% | ||
| Q3 25 | 33.3% | 65.0% | ||
| Q2 25 | 28.5% | 67.2% | ||
| Q1 25 | 30.7% | 65.1% | ||
| Q4 24 | 27.4% | 65.7% | ||
| Q3 24 | 33.2% | 66.2% | ||
| Q2 24 | 34.2% | 67.2% |
营业利润率ASHCLVT
| Q1 26 | — | 5.2% | ||
| Q4 25 | -1.6% | 6.7% | ||
| Q3 25 | 12.8% | 7.1% | ||
| Q2 25 | -152.9% | 1.1% | ||
| Q1 25 | 10.6% | -3.5% | ||
| Q4 24 | -44.2% | -9.4% | ||
| Q3 24 | 6.1% | 3.5% | ||
| Q2 24 | -11.2% | -36.9% |
净利率ASHCLVT
| Q1 26 | — | -6.9% | ||
| Q4 25 | -3.1% | 0.5% | ||
| Q3 25 | 6.5% | -4.5% | ||
| Q2 25 | -160.3% | -11.6% | ||
| Q1 25 | 6.5% | -17.5% | ||
| Q4 24 | -40.7% | -28.9% | ||
| Q3 24 | 3.3% | -10.5% | ||
| Q2 24 | 1.1% | -46.8% |
每股收益（稀释后）ASHCLVT
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $-0.26 | $0.00 | ||
| Q3 25 | $0.83 | $-0.04 | ||
| Q2 25 | $-16.21 | $-0.11 | ||
| Q1 25 | $0.65 | $-0.15 | ||
| Q4 24 | $-3.50 | $-0.27 | ||
| Q3 24 | $0.34 | $-0.09 | ||
| Q2 24 | $0.12 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | — |
| 总债务越低越好 | $1.4B | $4.3B |
| 股东权益账面价值 | $1.9B | $4.8B |
| 总资产 | $4.5B | $10.9B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ASHCLVT
| Q1 26 | — | — | ||
| Q4 25 | $304.0M | $329.2M | ||
| Q3 25 | $215.0M | $318.7M | ||
| Q2 25 | $207.0M | $362.6M | ||
| Q1 25 | $168.0M | $354.0M | ||
| Q4 24 | $219.0M | $295.2M | ||
| Q3 24 | $300.0M | $388.5M | ||
| Q2 24 | $399.0M | $376.4M |
总债务ASHCLVT
| Q1 26 | — | $4.3B | ||
| Q4 25 | $1.4B | $4.3B | ||
| Q3 25 | $1.4B | $4.4B | ||
| Q2 25 | $1.4B | $4.5B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | $1.3B | $4.5B | ||
| Q3 24 | $1.3B | $4.6B | ||
| Q2 24 | $1.3B | $4.6B |
股东权益ASHCLVT
| Q1 26 | — | $4.8B | ||
| Q4 25 | $1.9B | $4.8B | ||
| Q3 25 | $1.9B | $4.9B | ||
| Q2 25 | $1.9B | $5.0B | ||
| Q1 25 | $2.6B | $5.0B | ||
| Q4 24 | $2.6B | $5.1B | ||
| Q3 24 | $2.9B | $5.5B | ||
| Q2 24 | $3.0B | $5.6B |
总资产ASHCLVT
| Q1 26 | — | $10.9B | ||
| Q4 25 | $4.5B | $11.1B | ||
| Q3 25 | $4.6B | $11.2B | ||
| Q2 25 | $4.6B | $11.4B | ||
| Q1 25 | $5.2B | $11.5B | ||
| Q4 24 | $5.2B | $11.5B | ||
| Q3 24 | $5.6B | $12.0B | ||
| Q2 24 | $5.7B | $12.1B |
负债/权益比ASHCLVT
| Q1 26 | — | 0.89× | ||
| Q4 25 | 0.74× | 0.89× | ||
| Q3 25 | 0.73× | 0.90× | ||
| Q2 25 | 0.73× | 0.90× | ||
| Q1 25 | 0.52× | 0.90× | ||
| Q4 24 | 0.51× | 0.88× | ||
| Q3 24 | 0.47× | 0.84× | ||
| Q2 24 | 0.45× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $134.7M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $78.9M |
| 自由现金流率自由现金流/营收 | 28.8% | 13.5% |
| 资本支出强度资本支出/营收 | 3.6% | 9.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $333.9M |
8季度趋势，按日历期对齐
经营现金流ASHCLVT
| Q1 26 | — | $134.7M | ||
| Q4 25 | $125.0M | $159.9M | ||
| Q3 25 | $40.0M | $181.1M | ||
| Q2 25 | $115.0M | $116.3M | ||
| Q1 25 | $9.0M | $171.2M | ||
| Q4 24 | $-30.0M | $141.3M | ||
| Q3 24 | $80.0M | $202.9M | ||
| Q2 24 | $127.0M | $126.2M |
自由现金流ASHCLVT
| Q1 26 | — | $78.9M | ||
| Q4 25 | $111.0M | $89.2M | ||
| Q3 25 | $6.0M | $115.5M | ||
| Q2 25 | $95.0M | $50.3M | ||
| Q1 25 | $-12.0M | $110.3M | ||
| Q4 24 | $-53.0M | $59.1M | ||
| Q3 24 | $42.0M | $126.3M | ||
| Q2 24 | $98.0M | $60.3M |
自由现金流率ASHCLVT
| Q1 26 | — | 13.5% | ||
| Q4 25 | 28.8% | 14.5% | ||
| Q3 25 | 1.3% | 18.5% | ||
| Q2 25 | 20.5% | 8.1% | ||
| Q1 25 | -2.5% | 18.6% | ||
| Q4 24 | -13.1% | 8.9% | ||
| Q3 24 | 8.1% | 20.3% | ||
| Q2 24 | 18.0% | 9.3% |
资本支出强度ASHCLVT
| Q1 26 | — | 9.5% | ||
| Q4 25 | 3.6% | 11.5% | ||
| Q3 25 | 7.1% | 10.5% | ||
| Q2 25 | 4.3% | 10.6% | ||
| Q1 25 | 4.4% | 10.3% | ||
| Q4 24 | 5.7% | 12.4% | ||
| Q3 24 | 7.3% | 12.3% | ||
| Q2 24 | 5.3% | 10.1% |
现金转化率ASHCLVT
| Q1 26 | — | — | ||
| Q4 25 | — | 51.58× | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
